Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
European Urology
|
December 13, 2002
Superficial bladder tumors
Dominique K Chopin, Bernard Gattegno
European Urology
|
April 2, 2003
Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature
Fabien Saint, Laurent Salomon, Rodrigo Quintela, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 2006
[Complications of retroperitoneal laparoscopy based on a series of 500 cases]
Alexis Demey, Alexandre de la Taille, Dimitri Vordos, et al.
Cancer Letters
|
January 27, 2005
Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines
Sandra Huguenin, Francis Vacherot, Jocelyne Fleury-Feith, et al.
The Journal of Urology
|
December 18, 2001
Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer
Fabien Saint, Jean J Patard, Pascale Maille, et al.
Urologic Oncology
|
April 29, 2008
The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status
Marie E Fondrevelle, Bernadette Kantelip, Robert E Reiter, et al.
The Prostate
|
August 12, 2004
Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines
Sandra Huguenin, Jocelyne Fleury-Feith, Laurence Kheuang, et al.
Molecular Cancer Therapeutics
|
March 18, 2004
Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
Sandra Huguenin, Francis Vacherot, Laurence Kheuang, et al.
International Journal of Cancer
|
September 25, 2003
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy
Fabien Saint, Nathalie Kurth, Pascale Maille, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 19, 2003
Epidermal growth factor receptor regulates normal urothelial regeneration
Ahmad Daher, Willem I de Boer, Ahmed El-Marjou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
European Urology
|
December 13, 2002
Superficial bladder tumors
Dominique K Chopin, Bernard Gattegno
European Urology
|
April 2, 2003
Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature
Fabien Saint, Laurent Salomon, Rodrigo Quintela, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 2006
[Complications of retroperitoneal laparoscopy based on a series of 500 cases]
Alexis Demey, Alexandre de la Taille, Dimitri Vordos, et al.
Cancer Letters
|
January 27, 2005
Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines
Sandra Huguenin, Francis Vacherot, Jocelyne Fleury-Feith, et al.
The Journal of Urology
|
December 18, 2001
Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer
Fabien Saint, Jean J Patard, Pascale Maille, et al.
Urologic Oncology
|
April 29, 2008
The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status
Marie E Fondrevelle, Bernadette Kantelip, Robert E Reiter, et al.
The Prostate
|
August 12, 2004
Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines
Sandra Huguenin, Jocelyne Fleury-Feith, Laurence Kheuang, et al.
Molecular Cancer Therapeutics
|
March 18, 2004
Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
Sandra Huguenin, Francis Vacherot, Laurence Kheuang, et al.
International Journal of Cancer
|
September 25, 2003
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy
Fabien Saint, Nathalie Kurth, Pascale Maille, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 19, 2003
Epidermal growth factor receptor regulates normal urothelial regeneration
Ahmad Daher, Willem I de Boer, Ahmed El-Marjou, et al.
Page
of 3